Author

Alan S. Premasiri

Amyotrophic Lateral Sclerosis Therapy Development InstituteORCID 0000-0002-0261-9953Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anna L. GilliD· 1 shared Fernando G. VieiraiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anna L. GillORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Type I PRMT inhibition protects against C9ORF72 arginine-rich dipeptide repeat toxicity

Alan S. Premasiri, Anna L. Gill, Fernando G. Vieira

The paper identifies Type I PRMT inhibitors as potential therapeutics for polyGR- and polyPR-related toxicity by showing ADMe of polyGR is critical for its pathogenesis.

Frontiers in Pharmacology · Sep 8, 2020Peer-reviewedNeuroscience